ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Clinton’s FY97 Budget Sees $12.4 Billion For NIH, $2.28B For NCI

March 22, 1996

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 12, 1990

Colorado Center Delays New Core Grant Application

July 13, 1979

USC, Wisconsin Get Construction Grants Totaling $1.5 Million

March 23, 1990

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

May 1, 1998